Novartis appoints Merck executive as oncology chief

June 2 (Reuters) - Swiss drugmaker Novartis AG said it has appointed Bruno Strigini, one of Merck & Co Inc's top executives, to head its oncology unit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.